Contraceptive Use Among Reproductive Age Women with Cardiomyopathy
ACOG ePoster. Krinock D. Apr 27, 2018; 211428
Derek Krinock
Derek Krinock
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction: We sought to evaluate the rates and predictors of contraception in reproductive age women with cardiomyopathy.

Methods: A retrospective cohort study of women age 18-45 who were admitted with a known diagnosis of cardiomyopathy at a single urban tertiary care center between 5/2010 and 6/2016 was performed. Clinical charts were reviewed for clinical course, medication use and demographic data. The data was analyzed using chi-square and Mann Whitney U test. P less than 0.05 was considered significant.

Results: Among the 45 women with cardiomyopathy, 29% had an ejection fraction ≤30% and 80% were taking a medication recognized as potentially teratogenic. These included ACE inhibitors, Coumadin and others. Only 37% of the women were taking birth control. These included tubal ligation (n=11) and long acting reversible contraception (n=2). Women with a hysterectomy (n=4) were considered to have contraception. Women with contraception when compared to women without contraception were more likely to be married (53 vs 14%, p=0.04) and have a higher BMI (33 vs 27 kg/m2, p=0.04) but there was no difference in the utilization of public insurance (82 vs 75%, p=.71). They were more likely to have chronic hypertension (94 vs 50%, p=0.003) but less likely to be taking a medication which was potentially teratogenic (89 vs 64%, p=0.04). Overall, 30% of women taking a potentially teratogenic medication were on birth control.

Conclusion/Implications: Among women with cardiomyopathy, contraception is underutilized. A focus in this population is warranted in order to prevent maternal and infant morbidity and mortality.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings